Variant report

Variant	nsv899073
Chromosome Location	chr12:50335628-50360461
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:716)
CpG islands
(count:1710)
Chromatin interactive
region (count:60)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:716 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:50339300-50339716	K562	blood:	n/a	n/a
2	ATF2	chr12:50339302-50339688	GM12878	blood:	n/a	n/a
3	ATF2	chr12:50339294-50339708	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr12:50339288-50339683	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr12:50339312-50339729	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr12:50339207-50339537	K562	blood:	n/a	n/a
7	BATF	chr12:50339261-50339570	GM12878	blood:	n/a	chr12:50339433-50339444
8	BHLHE40	chr12:50348124-50348453	K562	blood:	n/a	n/a
9	BHLHE40	chr12:50336681-50336809	K562	blood:	n/a	n/a
10	BHLHE40	chr12:50339350-50339646	K562	blood:	n/a	n/a
11	BHLHE40	chr12:50360337-50361780	K562	blood:	n/a	n/a
12	BHLHE40	chr12:50356808-50357069	A549	lung:	n/a	n/a
13	BHLHE40	chr12:50356805-50357004	HepG2	liver:	n/a	n/a
14	BRCA1	chr12:50339387-50339657	HepG2	liver:	n/a	n/a
15	BRCA1	chr12:50339348-50340045	Hela-S3	cervix:	n/a	n/a
16	CBX3	chr12:50342834-50343091	K562	blood:	n/a	n/a
17	CBX3	chr12:50339330-50339664	K562	blood:	n/a	n/a
18	CBX3	chr12:50339100-50339747	K562	blood:	n/a	n/a
19	CCNT2	chr12:50339378-50339640	K562	blood:	n/a	n/a
20	CCNT2	chr12:50344176-50344311	K562	blood:	n/a	n/a
21	CEBPB	chr12:50339331-50339846	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr12:50342941-50342956	K562	blood:	n/a	n/a
23	CEBPB	chr12:50349758-50349786	Hela-S3	cervix:	n/a	chr12:50349769-50349780
24	CEBPB	chr12:50336740-50337044	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr12:50349648-50349830	HepG2	liver:	n/a	chr12:50349769-50349780
26	CEBPB	chr12:50341749-50341832	HepG2	liver:	n/a	n/a
27	CEBPB	chr12:50346977-50347377	Hela-S3	cervix:	n/a	n/a
28	CEBPB	chr12:50356748-50357096	Hela-S3	cervix:	n/a	n/a
29	CHD2	chr12:50339336-50339774	H1-hESC	embryonic stem cell:	n/a	n/a
30	CHD2	chr12:50339291-50339751	Hela-S3	cervix:	n/a	n/a
31	CHD2	chr12:50353482-50354376	Hela-S3	cervix:	n/a	n/a
32	CHD2	chr12:50339280-50339647	K562	blood:	n/a	n/a
33	CHD2	chr12:50356719-50357172	Hela-S3	cervix:	n/a	n/a
34	CHD2	chr12:50336768-50337101	Hela-S3	cervix:	n/a	n/a
35	CREB1	chr12:50339253-50339739	H1-hESC	embryonic stem cell:	n/a	n/a
36	CREB1	chr12:50339325-50339644	A549	lung:	n/a	n/a
37	CREB1	chr12:50339303-50339613	A549	lung:	n/a	n/a
38	CTBP2	chr12:50339242-50339676	H1-hESC	embryonic stem cell:	n/a	n/a
39	CTCF	chr12:50339358-50339666	GM13977	blood:	n/a	n/a
40	CTCF	chr12:50339160-50339677	GM19238	blood:	n/a	n/a
41	CTCF	chr12:50339400-50339550	GM12878	blood:	n/a	n/a
42	CTCF	chr12:50339460-50339610	AoAF	blood vessel:	n/a	n/a
43	CTCF	chr12:50339343-50339666	Fibrobl	skin:	n/a	n/a
44	CTCF	chr12:50339400-50339550	NHEK	skin:	n/a	n/a
45	CTCF	chr12:50347740-50347890	GM12864	blood:	n/a	chr12:50347845-50347854 chr12:50347842-50347852 chr12:50347859-50347867
46	CTCF	chr12:50339380-50339530	HCM	heart:	n/a	n/a
47	CTCF	chr12:50348982-50349074	NHEK	skin:	n/a	n/a
48	CTCF	chr12:50360260-50360410	SAEC	small airway:	n/a	n/a
49	CTCF	chr12:50339440-50339590	Caco-2	colon:	n/a	n/a
50	CTCF	chr12:50360320-50360470	HAc	cerebellar:	n/a	n/a

(count:1710 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:50357352-50357402	ovcar-3	ovarian:	n/a
2	chr12:50354962-50355012	PFSK-1	brain:	n/a
3	chr12:50357352-50357402	ovcar-3	ovarian:	n/a
4	chr12:50354962-50355012	PFSK-1	brain:	n/a
5	chr12:50339482-50339532	ECC-1	luminal epithelium:	n/a
6	chr12:50344211-50344261	HCM	heart:	n/a
7	chr12:50355307-50355357	HIPEpiC	eye:	n/a
8	chr12:50355995-50356045	HRPEpiC	eye:	n/a
9	chr12:50349522-50349572	SKMC	muscle:	n/a
10	chr12:50344458-50344508	AG10803	skin:	n/a
11	chr12:50344548-50344598	MCF10A-Er-Src	breast:	n/a
12	chr12:50359051-50359101	AG04450	lung:	fetal
13	chr12:50350299-50350349	AG04450	lung:	fetal
14	chr12:50344548-50344598	T-47D	breast:	n/a
15	chr12:50339186-50339236	GM19239	blood:	n/a
16	chr12:50351980-50352030	A549	lung:	n/a
17	chr12:50347628-50347678	HMEC	breast:	n/a
18	chr12:50344463-50344513	MCF-7	breast:	n/a
19	chr12:50344458-50344508	HEEpiC	esophagus:	n/a
20	chr12:50354840-50354890	PFSK-1	brain:	n/a
21	chr12:50359051-50359101	BJ	skin:	n/a
22	chr12:50339186-50339236	H1-hESC	embryonic stem cell:	embryo
23	chr12:50347628-50347678	ovcar-3	ovarian:	n/a
24	chr12:50356869-50356919	HCPEpiC	choroid plexus:	n/a
25	chr12:50354998-50355048	HCF	heart:	n/a
26	chr12:50339482-50339532	HCM	heart:	n/a
27	chr12:50339482-50339532	GM19239	blood:	n/a
28	chr12:50357352-50357402	AG04450	lung:	fetal
29	chr12:50339482-50339532	Hela-S3	cervix:	n/a
30	chr12:50357352-50357402	GM12891	blood:	n/a
31	chr12:50339529-50339579	GM12891	blood:	n/a
32	chr12:50354998-50355048	SAEC	small airway:	n/a
33	chr12:50354998-50355048	HRPEpiC	eye:	n/a
34	chr12:50349329-50349379	RPTEC	kidney:	n/a
35	chr12:50349307-50349357	BJ	skin:	n/a
36	chr12:50353951-50354001	AG04449	skin:	fetal
37	chr12:50350299-50350349	HCPEpiC	choroid plexus:	n/a
38	chr12:50355821-50355871	HRPEpiC	eye:	n/a
39	chr12:50339482-50339532	H1-hESC	embryonic stem cell:	embryo
40	chr12:50354962-50355012	HRPEpiC	eye:	n/a
41	chr12:50355821-50355871	PrEC	prostate:	n/a
42	chr12:50344548-50344598	AoSMC	blood vessel:	n/a
43	chr12:50339529-50339579	AG09309	skin:	n/a
44	chr12:50351980-50352030	K562	blood:	n/a
45	chr12:50339482-50339532	HAEpiC	amniotic membrane:	n/a
46	chr12:50349173-50349223	A549	lung:	n/a
47	chr12:50339482-50339532	HRCEpiC	kidney:	n/a
48	chr12:50344463-50344513	NHDF-neo	bronchial:	n/a
49	chr12:50344475-50344525	AG09319	gingival:	n/a
50	chr12:50355307-50355357	HEK293	kidney:	embryo

(count:60 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr12:50338497..50339666-chr12:50360120..50361429,3	MCF-7	breast:
2	chr12:50353765..50356841-chr12:50356981..50360242,4	MCF-7	breast:
3	chr12:50348137..50350764-chr12:50360835..50363285,2	K562	blood:
4	chr12:50359856..50363195-chr12:50464299..50467277,4	MCF-7	breast:
5	chr12:50260815..50261690-chr12:50339307..50339942,3	MCF-7	breast:
6	chr12:50360101..50361853-chr12:50463828..50465034,15	K562	blood:
7	chr12:50221943..50223980-chr12:50339325..50341007,2	K562	blood:
8	chr12:50359402..50360099-chr12:50450046..50450669,2	MCF-7	breast:
9	chr12:50358725..50360961-chr12:50462832..50465036,2	K562	blood:
10	chr12:50330026..50331634-chr12:50334635..50337169,2	MCF-7	breast:
11	chr12:50169842..50170749-chr12:50338718..50339494,2	K562	blood:
12	chr12:50336938..50340319-chr12:50341822..50344338,4	K562	blood:
13	chr12:50287732..50289351-chr12:50337980..50339700,2	MCF-7	breast:
14	chr12:50331211..50335185-chr12:50337113..50339426,3	MCF-7	breast:
15	chr12:50169804..50170372-chr12:50339425..50339966,2	MCF-7	breast:
16	chr12:50336622..50338701-chr12:50446890..50448853,2	MCF-7	breast:
17	chr12:50352910..50356046-chr12:50357826..50360762,4	K562	blood:
18	chr12:50338925..50340024-chr12:50360474..50361632,7	K562	blood:
19	chr12:50261163..50264047-chr12:50337700..50340324,2	MCF-7	breast:
20	chr12:50347426..50349461-chr12:50350672..50352646,2	K562	blood:
21	chr12:50347500..50349334-chr12:50448823..50450713,2	MCF-7	breast:
22	chr12:50338638..50340255-chr12:50342218..50344321,2	K562	blood:
23	chr12:50360085..50362096-chr12:50467242..50469135,2	K562	blood:
24	chr12:50339184..50339885-chr12:50463898..50464594,2	MCF-7	breast:
25	chr12:50336938..50340319-chr12:50341822..50344338,4	K562	blood:
26	chr12:50302479..50304923-chr12:50336805..50339549,2	MCF-7	breast:
27	chr12:50292614..50294195-chr12:50340396..50343074,2	K562	blood:
28	chr12:50334465..50337544-chr12:50338372..50341772,4	K562	blood:
29	chr12:50343242..50347399-chr12:50348384..50352542,7	K562	blood:
30	chr1:17231927..17232615-chr12:50353208..50354029,2	Hela-S3	cervix:
31	chr12:50338558..50341156-chr12:50354977..50356831,3	MCF-7	breast:
32	chr12:50323141..50325275-chr12:50334464..50336385,2	MCF-7	breast:
33	chr12:50353124..50353737-chr4:120987285..120988120,2	Hela-S3	cervix:
34	chr12:50347426..50349461-chr12:50350672..50352646,2	K562	blood:
35	chr12:50358386..50360982-chr12:50417949..50420523,2	MCF-7	breast:
36	chr12:50235392..50237047-chr12:50351829..50354017,3	MCF-7	breast:
37	chr12:50262671..50263209-chr12:50339105..50339936,2	MCF-7	breast:
38	chr12:50360045..50361666-chr12:50451717..50454140,2	MCF-7	breast:
39	chr12:50335624..50338438-chr12:50341957..50344338,2	K562	blood:
40	chr12:50340163..50342999-chr12:50343343..50345354,2	MCF-7	breast:
41	chr12:50341404..50344763-chr12:50349477..50352440,3	MCF-7	breast:
42	chr12:50353349..50353967-chr7:86781674..86782611,2	Hela-S3	cervix:
43	chr12:50358701..50362803-chr12:50449341..50451682,4	MCF-7	breast:
44	chr12:50348029..50350628-chr12:50451106..50452724,2	MCF-7	breast:
45	chr12:50356903..50358406-chr12:50425731..50427880,2	MCF-7	breast:
46	chr12:50308354..50310018-chr12:50335915..50338737,2	K562	blood:
47	chr12:50338638..50340255-chr12:50342218..50344321,2	K562	blood:
48	chr12:50340512..50342652-chr12:50346476..50349381,2	MCF-7	breast:
49	chr12:50341404..50344763-chr12:50349477..50352440,3	MCF-7	breast:
50	chr12:50353765..50356841-chr12:50356981..50360242,4	MCF-7	breast:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RACGAP1-1	chr12:50345702-50345871	ENSG00000257588.1
2	lnc-RACGAP1-1	chr12:50345295-50345452	ENSG00000257588.1
3	lnc-RACGAP1-1	chr12:50356450-50356566	ENSG00000257588.1
4	lnc-RACGAP1-1	chr12:50356450-50356707	ENSG00000257588.1
5	lnc-RACGAP1-2	chr12:50348422-50348440	ENSG00000257378.1
6	lnc-RACGAP1-2	chr12:50349368-50349908	ENSG00000257378.1
7	lnc-RACGAP1-1	chr12:50352655-50353427	ENSG00000257588.1

No data

Variant related genes	Relation type
ENSG00000257378	TF binding region
AQP2	TF binding region
ENSG00000257588	TF binding region
AQP5	TF binding region
AQP6	TF binding region
ENSG00000257378	CpG island
AQP2	CpG island
ENSG00000257588	CpG island
AQP5	CpG island
AQP6	CpG island
ENSG00000250938	chromatin interactions
ENSG00000186666	chromatin interactions
ENSG00000257378	chromatin interactions
ENSG00000167566	chromatin interactions
ENSG00000135472	chromatin interactions
ENSG00000257771	chromatin interactions
ENSG00000110881	chromatin interactions
ENSG00000258057	chromatin interactions
ENSG00000224046	chromatin interactions
ENSG00000161798	chromatin interactions
ENSG00000161800	chromatin interactions
ENSG00000135164	chromatin interactions
ENSG00000257588	chromatin interactions
ENSG00000164109	chromatin interactions
ENSG00000086159	chromatin interactions
ENSG00000167580	chromatin interactions

Extended variants
information (count: 1150 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:1150 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17124176	chr12:50335628-50335629	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs78529771	chr12:50335634-50335635	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs112801116	chr12:50335636-50335637	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs546393820	chr12:50335661-50335662	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs562901051	chr12:50335681-50335682	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs146072343	chr12:50335685-50335686	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs542153814	chr12:50335692-50335693	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs561386277	chr12:50335751-50335752	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs139690860	chr12:50335765-50335766	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs564097562	chr12:50335795-50335796	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs547116261	chr12:50335841-50335842	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs187958579	chr12:50335848-50335849	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs532852315	chr12:50335850-50335851	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs549955140	chr12:50335861-50335862	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs569749583	chr12:50335865-50335866	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs535783508	chr12:50335866-50335867	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs555687370	chr12:50335930-50335931	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs568497293	chr12:50335997-50335998	Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs551164138	chr12:50336006-50336007	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs534207403	chr12:50336020-50336021	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs554174759	chr12:50336116-50336117	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs577278680	chr12:50336124-50336125	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs76189028	chr12:50336185-50336186	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs77378853	chr12:50336195-50336196	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs576549556	chr12:50336209-50336210	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs542150925	chr12:50336218-50336219	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs149759702	chr12:50336248-50336249	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs527948701	chr12:50336271-50336272	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs540639027	chr12:50336286-50336287	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs563695493	chr12:50336306-50336307	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs75519304	chr12:50336311-50336312	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs549602663	chr12:50336361-50336362	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs555410800	chr12:50336378-50336379	Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs144845550	chr12:50336402-50336403	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs191982565	chr12:50336414-50336415	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs35775147	chr12:50336419-50336420	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs549172454	chr12:50336442-50336443	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs565996342	chr12:50336503-50336504	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs534877217	chr12:50336512-50336513	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs547816175	chr12:50336540-50336541	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs182973892	chr12:50336635-50336636	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs416959	chr12:50336638-50336639	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs532821697	chr12:50336672-50336673	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs576603799	chr12:50336677-50336678	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs76983131	chr12:50336716-50336717	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs555503735	chr12:50336717-50336718	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs35186320	chr12:50336733-50336734	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs187427237	chr12:50336747-50336748	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs541277834	chr12:50336766-50336767	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs370890253	chr12:50336774-50336775	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Hirschsprung''s Disease	21712996	CNVD
Lissencephaly	21572526	CNVD
Lung cancer	18438408	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	19602461	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Follicular lymphoma	20505157	CNVD
Hepatocellular carcinoma	16750200	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Glioblastoma multiforme	17387387	CNVD
liposarcomas	17372913	CNVD
Non-small cell lung cancer	24170126	CNVD
Cancer	16751803	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	16616336	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	17661082	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21785460	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Intracranial ependymoma	16609018	CNVD
Cancer	17160897	CNVD
Melanoma	20877625	CNVD
Cancer	20164919	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:921 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:50323400-50338800	Weak transcription	H9 Cell Line	embryonic stem cell
2	chr12:50327200-50338600	Weak transcription	Fetal Thymus	thymus
3	chr12:50328800-50335800	Weak transcription	Hela-S3	cervix
4	chr12:50331000-50338800	Weak transcription	Fetal Brain Female	brain
5	chr12:50332400-50336800	Weak transcription	Gastric	stomach
6	chr12:50332600-50336200	Weak transcription	NHEK	skin
7	chr12:50332600-50336800	Weak transcription	HMEC	breast
8	chr12:50332800-50336800	Weak transcription	Pancreas	Pancrea
9	chr12:50333400-50336400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr12:50333800-50336400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr12:50333800-50336400	Weak transcription	Fetal Lung	lung
12	chr12:50333800-50338600	Weak transcription	Right Atrium	heart
13	chr12:50334000-50335800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr12:50334000-50336200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr12:50334000-50336800	Weak transcription	Stomach Mucosa	stomach
16	chr12:50334000-50339200	Weak transcription	Lung	lung
17	chr12:50334800-50335800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr12:50334800-50335800	Weak transcription	Esophagus	oesophagus
19	chr12:50335400-50336000	Enhancers	Fetal Brain Male	brain
20	chr12:50335400-50336400	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr12:50335400-50336400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
22	chr12:50335400-50337600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
23	chr12:50335600-50339200	Enhancers	Primary neutrophils fromperipheralblood	blood
24	chr12:50335800-50336000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr12:50335800-50336400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
26	chr12:50335800-50336400	Enhancers	Hela-S3	cervix
27	chr12:50335800-50336800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr12:50335800-50337800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
29	chr12:50335800-50337800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
30	chr12:50335800-50338200	Enhancers	Esophagus	oesophagus
31	chr12:50335800-50338200	Enhancers	Spleen	Spleen
32	chr12:50335800-50338800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
33	chr12:50336000-50336800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
34	chr12:50336000-50337400	Enhancers	Primary T helper cells PMA-I stimulated	--
35	chr12:50336000-50337800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr12:50336000-50339200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
37	chr12:50336200-50337000	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr12:50336200-50337400	Enhancers	Primary T cells fromperipheralblood	blood
39	chr12:50336200-50337400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr12:50336200-50337400	Enhancers	NHEK	skin
41	chr12:50336200-50339800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
42	chr12:50336200-50340000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
43	chr12:50336400-50336600	Enhancers	HUES64 Cell Line	embryonic stem cell
44	chr12:50336400-50336600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
45	chr12:50336400-50337000	Enhancers	ES-I3 Cell Line	embryonic stem cell
46	chr12:50336400-50337400	Enhancers	H1 Cell Line	embryonic stem cell
47	chr12:50336400-50337400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
48	chr12:50336400-50337400	Enhancers	Primary T helper cells fromperipheralblood	blood
49	chr12:50336400-50337400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
50	chr12:50336400-50338000	Flanking Active TSS	Hela-S3	cervix

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links